Promoting Illiteracy in Epigenetics: An Emerging Therapeutic Strategy
نویسندگان
چکیده
منابع مشابه
Promoting Illiteracy in Epigenetics: An Emerging Therapeutic Strategy
On the 10 th anniversary of the announcement of the draft sequence of the 3 billion DNA bases in the genome by the Human Genome Project, there is still a lack of molecular targeted therapies for previously intractable diseases. It has become clear that the genomes within and across species are too similar to explain the diversity of life and the etiology of all diseases, indicating that the und...
متن کاملEpigenetics: an emerging player in gastric cancer.
Cancers, like other diseases, arise from gene mutations and/or altered gene expression, which eventually cause dysregulation of numerous proteins and noncoding RNAs. Changes in gene expression, i.e., upregulation of oncogenes and/or downregulation of tumor suppressor genes, can be generated not only by genetic and environmental factors but also by epigenetic factors, which are inheritable but n...
متن کاملdevelopment and implementation of an optimized control strategy for induction machine in an electric vehicle
in the area of automotive engineering there is a tendency to more electrification of power train. in this work control of an induction machine for the application of electric vehicle is investigated. through the changing operating point of the machine, adapting the rotor magnetization current seems to be useful to increase the machines efficiency. in the literature there are many approaches wh...
15 صفحه اولEpigenetics: an emerging player in health and disease.
THE DECODING of the human genome in 2003 provided enormous opportunities to gain a greater understanding of the genetic intricacies underlying biological systems in both health and disease. Along with variations in the linear sequence of the genome that may predispose to certain pathologies, there is increasing evidence that epigenetic factors can profoundly influence gene expression and, in tu...
متن کاملnts: An Emerging Treatment Strategy
wnloade ical trials evaluating combinations of targeted agents with bortezomib, the first-in-class proteainhibitor, have been initiated, with the objective of enhancing its single agent activity in hemac malignancies (myeloma, mantle cell lymphoma), as well as expanding its efficacy in solid s. In most cases, preclinical studies have provided a supportive rationale for designing these et combin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Chemical Genomics
سال: 2011
ISSN: 1875-3973
DOI: 10.2174/1875397301005010048